SEE FULL COMPANY PROFILES WITH A FREE TRIAL
EMIS is the definitive emerging markets news, research, company, and financial data resource. EMIS - ISI Emerging MarketsLEARN MORE
Search for another company:
ALL
South Africa
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).

ADCOCK INGRAM HOLDINGS LTD

Main Activities: Chemical Manufacturing - Pharmaceutical and Medicine Manufacturing - Drugs and Druggists' Sundries Merchant Wholesalers

Secondary Activities: Health and Personal Care Stores

facebook Please check the full coverage of information what EMIS can offer you. SEE SAMPLE

Company Information

Full name
ADCOCK INGRAM HOLDINGS LTD

Headquarters
1 New Road, (c/o New Road & 7th Street), Midrand, South Africa ; Johannesburg; Gauteng
Status: Listed
Legal Form: Limited Liability Company
Operational Status: Operational
Financial Auditors: Ernst & Young (2009)
Total Employees: 277

Tel: +27 11 635 0122

Company Description

Adcock Ingram provides an extensive portfolio of branded and generic medicines, has a strong presence in over-the-counter brands, is South Africa's largest supplier of hospital and critical-care products and supplies established brand name consumables and equipment to medical, research and servicing pathology laboratories.

Company Analysis

According to the Consolidated - Audited financial statement for the Year of 2010, total net operating revenues increased with 10.87%, from ZAR 4,005,153 thousands to ZAR 4,440,654 thousands. Operating result increased from ZAR 1,132,200 thousands to ZAR 1,155,660 thousands which means 2.07% change. The results of the period decreased -46.21% reaching ZAR 355,997 thousands at the end of the period against ZAR 661,825 thousands last year. Return on equity (Net income/Total equity) went from 28.46% to 11.58%, the Return On Asset (Net income / Total Asset) went from 21.47% to 8.22% and the Net Profit Margin (Net Income/Net Sales) went from 16.52% to 8.02% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 54.79% compared to 46.73% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 2.50 to 2.77 when compared to the previous year.

Key Executives

Dr JJ Louw Chief Executive Officer
Dr KDK Mokhele Independent Non-Executive Chairman
Dr RI Stewart Independent Non-Executive Director
Dr T Lesoli Independent Non-Executive Director
Mr AG Hall Chief Financial Officer
More

Companies with Similar Main Activities

ISI Emerging Markets

FULL COMPANY PROFILE

Please check the full coverage of information what EMIS can offer you.
SEE SAMPLE
SELECT CURRENCY
Balance Sheet

Total Assets

5,235,460

4,757,345

Current Assets

3,201,443

3,300,546

Total Liabilities

2,012,080

1,684,005

Shareholders Equity

3,223,380

3,073,340

Current Liabilities

1,557,398

1,190,406

* All the accounts are in ZAR.
Income Statement

Total Operating Revenue

1,288,896

1,155,660

Operational Profit (Loss)

1,288,896

1,155,660

* All the accounts are in ZAR.
Ratios
Profitability Ratios

Return on Assets (ROA)

18.15%

14.84%

Annualised Return on Assets (ROA)

18.15%

14.84%

Return on Equity (ROE)

24.6%

20.93%

Return on Capital

24.6%

20.93%

Gross Profit Margin

100%

100%

Operating Profit Margin

100%

100%

Efficiency Ratios

Accounts Receivable Turnover

42.76x

Current asset turnover

0.40x

0.35x

Fixed-asset turnover

1.11x

1.35x

Asset Turnover

0.29x

0.27x

Valuation figures and ratios

Earning Before Interests and Taxes (EBIT)

1,068,638

931,302

EBITDA

1,170,005

1,032,894

Enterprise value

1,233,314,305

1,196,006,285

Enterprise Value / EBITDA

1,054.11

1,157.92

Bookvalue (BV)

2,357,476

2,649,191

Net Cash

-453,421

240,511

Liquidity Ratios

Current Ratio

205.56%

277.26%

Quick ratio

150.06%

216.84%

Doom's day ratio

70.89%

120.2%

Leverage Ratios

Leverage ratio

135.56%

140.99%

Debt to equity

62.42%

54.79%

Debt to total assets

46.05%

38.86%

Debt / Enterprise Value

0.16%

0.14%

Market ratios

Price/Book Ratio

2,710.54

2,282.23

Market Cap / Net cash

-2,722.43

4,978.67

Trend Ratios

Revenue Trend

111.53%

93.51%

Operating Income Trend

111.53%

93.51%